Biggest News Aggregation in the World
📰 Project Bioshield News

Page 5 - Project Bioshield News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Project Bioshield. Real-time updates on events, politics, business and more.

Soligenix Announces Scheduling of Type A Meeting with the U.S. FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
United States Christopherj Schaber Us Congress Us Development While The Company Drug Administration

Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J., May 4, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and... | May 4, 2023
Brian Poligone Christopherj Schaber Drug Administration Exchange Commission Development Authority Prnewswire Soligenix Inc

Soligenix Enters into Exclusive Option Agreement with Silk Road Therapeutics for Rights to Topical Pentoxifylline Designed to Treat Behçet's Disease

Phase 2/3-Ready Orphan Disease Program Complements Companys Existing Late-Stage Rare Disease Pipeline PRINCETON, N.J., May 1, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage... | May 1, 2023
United States Christopherj Schaber Defense Threat Reduction Agency Drug Administration Us Development Us Congress

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Soligenix Submits Type A Meeting Request to U.S. FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma

Meeting expected to occur approximately 30 days from the FDAs receipt of meeting request PRINCETON, N.J., April 24, 2023 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical... | June 18, 2023
United States Christopherj Schaber Exchange Commission Biomedical Advanced Research Our Public Health Solutions Soligenix Inc

Bush-Era Actions Have Boosted Coronavirus Response Efforts

The coronavirus pandemic is straining most federal and state emergency resources. But the strain—and the government’s response—would have been far worse, if legislation enacted in the previous decade had not laid a solid foundation of expanded homeland security and emergency medical preparedness. The Department of Homeland Security (DHS) was created in response to the 9/11 terrorist attacks—but that wasn’t the only impetus. Another significant motivating factor was the 2001 anthrax att...
United States George Bush National Pharmaceutical Science Technology Directorate Human Services National Bio

Letter on Reauthorization of the Pandemic and All-Hazards Preparedness Act - National Governors Association

Governors have firsthand experience on how to improve the ability of states and territories to respond to public health crises, gaps in the PAHPA framework, and ways to bolster partnerships between the federal government, states/territories and localities, the private sector, and NGO stakeholders.
Department Of Education District Of Columbia United States White House Bernie Sanders Ned Lamont
Source: nga.org

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science